Exane Derivatives’s iShares MSCI China ETF MCHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3.43M Sell
61,556
-32,627
-35% -$1.67M 1.97% 8
2022
Q1
$4.98M Buy
94,183
+94,170
+724,385% +$5.54M 1.4% 8
2021
Q4
$816 Hold
13
﹤0.01% 725
2021
Q3
$878 Hold
13
﹤0.01% 876
2021
Q2
$1.02K Hold
13
﹤0.01% 877
2021
Q1
$1.06K Sell
13
-63,945
-100% -$5.61M ﹤0.01% 727
2020
Q4
$5.18M Sell
63,958
-60,884
-49% -$4.82M 1.52% 9
2020
Q3
$9.26M Sell
124,842
-47,143
-27% -$3.45M 2.68% 6
2020
Q2
$11.3M Buy
171,985
+171,976
+1,910,844% +$10.6M 3.01% 3
2020
Q1
$515 Sell
9
-143,726
-100% -$8.89M ﹤0.01% 594
2019
Q4
$9.59M Buy
143,735
+143,230
+28,362% +$8.57M 1.78% 7
2019
Q3
$28.3K Sell
505
-146,949
-100% -$8.46M 0.01% 388
2019
Q2
$8.76M Buy
147,454
+41,542
+39% +$2.5M 1.54% 11
2019
Q1
$6.61M Buy
+105,912
New +$6.25M 1.31% 16

Other funds holding MCHI

Exane Derivatives's MCHI Position: Q2 2022 in Review

Exane Derivatives reduced its iShares MSCI China ETF (MCHI) stake by 35% in Q2 2022, selling an estimated $1.67M and leaving 61,556 shares worth $3.43M. The position accounts for 1.97% of the portfolio, ranked #8.

Exane Derivatives first reported a position in MCHI in Q1 2019 and has held it in 14 quarters since. The position peaked at $11.3M in Q2 2020. 257 funds tracked by Wall St. Rank hold MCHI as of Q2 2022.

  • Exane Derivatives held 61,556 shares of iShares MSCI China ETF worth $3.43M as of Q2 2022.
  • Exane Derivatives sold 32,627 iShares MSCI China ETF shares in Q2 2022, an estimated $1.67M.
  • iShares MSCI China ETF made up 1.97% of Exane Derivatives's portfolio in Q2 2022, its #8 holding.
  • Exane Derivatives first reported a position in iShares MSCI China ETF in Q1 2019 and has held it in 14 quarters since.
  • Exane Derivatives's iShares MSCI China ETF position peaked at $11.3M in Q2 2020.
  • 257 funds tracked by Wall St. Rank held iShares MSCI China ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.